购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

LMPTP INHIBITOR 1 hydrochloride

Rating icon 还可以
产品编号 T4491Cas号 2310135-38-5
别名 LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))

LMPTP INHIBITOR 1 hydrochloride 是一种高选择性的低分子量蛋白酪氨酸磷酸酶 (LMPTP) 抑制剂。LMPTP INHIBITOR 1 (hydrochloride) 能够抑制 LMPTP-A 的活性,IC50值为 0.8 μM。

LMPTP INHIBITOR 1 hydrochloride

LMPTP INHIBITOR 1 hydrochloride

Rating icon 还可以
纯度: 99.63%
产品编号 T4491 别名 LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))Cas号 2310135-38-5

LMPTP INHIBITOR 1 hydrochloride 是一种高选择性的低分子量蛋白酪氨酸磷酸酶 (LMPTP) 抑制剂。LMPTP INHIBITOR 1 (hydrochloride) 能够抑制 LMPTP-A 的活性,IC50值为 0.8 μM。

规格价格库存数量
1 mg¥ 1,780现货
5 mg¥ 4,480现货
10 mg¥ 6,380现货
25 mg¥ 9,620现货
50 mg¥ 12,9006-8周
1 mL x 10 mM (in DMSO)¥ 4,990现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"LMPTP INHIBITOR 1 hydrochloride"的相关化合物库

选择批次:
纯度:99.63%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
LMPTP INHIBITOR 1 hydrochloride is a selective inhibitor of low molecular weight protein tyrosine phosphatase ( LMPTP ), with an IC 50 of 0.8 μM for LMPTP-A.
靶点活性
LMPTPA:0.8 μM
体外活性
LMPTP INHIBITOR 1 (hydrochloride) 是一种对低分子量蛋白质酪氨酸磷酸酶具有选择性抑制作用的抑制剂,对LMPTP-A的IC 50值为0.8 μM。LMPTP INHIBITOR 1 对LMPTP-A的抑制效果较之于LMPTP-B更为强大。LMPTP抑制剂1还在人类HepG2肝细胞中,通过胰岛素刺激后增强了HepG2 IR的磷酸化[1]。
体内活性
LMPTP inhibitor 1 具有口服生物可用性,0.03% w/w 的处理约产生 680 nM 的平均血清浓度,而0.05% w/w 的处理则产生 >3 μM;该物质还能逆转肥胖小鼠的糖尿病。LMPTP inhibitor 1(0.05% w/w)抑制 LMPTP 活性,显著改善糖尿病 DIO 小鼠的葡萄糖耐受性并降低空腹胰岛素水平,但不影响体重[1]。
激酶实验
Phosphatase assays are performed in buffer containing 50 mM Bis-Tris, pH 6.0, 1 mM DTT and 0.01% Triton X-100 at 37°C. For assays conducted with 3-O-methylfluorescein phosphate (OMFP) as substrate, fluorescence is monitored continuously at λex = 485 and λem = 525 nm. For assays conducted with para-nitrophenyl phosphate (pNPP) as substrate, the reaction is stopped by addition of 2X reaction volume of 1 M NaOH, and absorbance is measured at 405 nm. IC50 values are determined from plots of LMPTP inhibitor 1 concentration versus percentage of enzyme activity. For inhibitor selectivity assays, each PTP is incubated with either 0.4 mM OMFP or 5 mM pNPP in the presence of 40 μM LMPTP inhibitor 1 or DMSO. Equal units of enzyme activity, comparable to the activity of 10 nM human LMPTP-A, are used. For the inhibitor reversibility assay, 50 nM human LMPTP-A is pre-incubated with 10 μM LMPTP inhibitor 1 or DMSO for 5 min. The enzyme is diluted 100X in phosphatase assay buffer containing 0.4 mM OMFP and fluorescence is measured at the indicated time points [1].
细胞实验
Human HepG2 cells are cultured in Eagle's Minimal Essential Medium (ATCC) containing 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin. The absence of Mycoplasma contamination in HepG2 cultures is confirmed using the Lonza MycoAlert Mycoplasma Detection Kit. Cells are treated with 10 μM LMPTP inhibitor 1 in serum-starvation media (0.1% FBS) overnight, following which cells are stimulated with 10 nM bovine insulin for 5 min at 37°C. For detection of IR tyrosine phosphorylation by immunoprecipitation/Western blotting, cells are lysed in radioimmunoprecipitation assay buffer containing 1 mM phenylmethylsulfonyl fluoride, 10 μg/mL aprotinin/leupeptin, 10 mM sodium orthovanadate, 5 mM sodium fluoride, and 2 mM sodium pyrophosphate, and the IR is immunoprecipitated using the anti-IRβ Ab. IR tyrosine phosphorylation of immunoprecipitates is determined by Western blotting with the anti-pIR/pIGFR-Y1162/Y1163 Ab [1].
动物实验
LMPTP inhibitor 1 is administered to male B6 or Acp1fl/fl albumin-Cre+ DIO mice at 0.05% w/w in high-fat diet (HFD) rodent chow. Control groups consist of male B6 or Acp1fl/fl albumin-Cre+ littermate mice administered HFD rodent chow alone. Mice are allowed food and water ad libitum and weighed daily. Randomization is not used in these experiments; rather littermate mice are assigned to treatment or control groups in a manner to maintain similar mean body weights between the 2 groups at the start of the study. Insulin-induced liver IR phosphorylation, IPGTT, and fasting insulin levels are assessed after treatment. Diabetic (displaying overnight [13 hr] fasting blood glucose levels ≥140 mg/dL) B6 DIO mice are used in experiments to assess IPGTT and fasting insulin levels [1].
别名LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
化学信息
分子量481.07
分子式C28H37ClN4O
CAS No.2310135-38-5
SmilesCCN(C(c1ccc(c(cc2NCCCN3CCCCC3)nc4c2cccc4)cc1)=O)CC.Cl
密度no data available
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 9 mg/mL (18.71 mM)
溶液配制表
1mg5mg10mg50mg
1 mM2.0787 mL10.3935 mL20.7870 mL103.9350 mL
5 mM0.4157 mL2.0787 mL4.1574 mL20.7870 mL
10 mM0.2079 mL1.0393 mL2.0787 mL10.3935 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy LMPTP INHIBITOR 1 hydrochloride | purchase LMPTP INHIBITOR 1 hydrochloride | LMPTP INHIBITOR 1 hydrochloride cost | order LMPTP INHIBITOR 1 hydrochloride | LMPTP INHIBITOR 1 hydrochloride chemical structure | LMPTP INHIBITOR 1 hydrochloride in vivo | LMPTP INHIBITOR 1 hydrochloride in vitro | LMPTP INHIBITOR 1 hydrochloride formula | LMPTP INHIBITOR 1 hydrochloride molecular weight